Viewing StudyNCT00478426



Ignite Creation Date: 2024-05-05 @ 5:33 PM
Last Modification Date: 2024-10-26 @ 9:33 AM
Study NCT ID: NCT00478426
Status: COMPLETED
Last Update Posted: 2020-02-17
First Post: 2007-05-23

Brief Title: Sunitinib Malate in Treating Patients With Recurrent or Metastatic Endometrial Cancer
Sponsor: National Cancer Institute NCI
Organization: National Cancer Institute NCI

Conditions & Keywords Data

Conditions:
Name
Uterine Corpus Carcinosarcoma
Endometrial Adenocarcinoma
Endometrial Endometrioid Adenocarcinoma
Endometrial Serous Adenocarcinoma
Recurrent Uterine Corpus Carcinoma
Stage IVA Uterine Corpus Cancer AJCC v7
Stage IVB Uterine Corpus Cancer AJCC v7
Uterine Carcinosarcoma
Keywords: